National Webinar - Bridging the Gap

May 27, 2021 1:00 PM to 2:00 PMOnline - Eastern Time

Area of Interest: Benefits Format: Web

Increasing private sector drug benefit plan sustainability

In Canada, generic medicines are dispensed to fill 73% of all prescriptions but there is a wide discrepancy between public and private sector generic utilization. Public sector drug plan generic utilization rates average 77% while the average for private sector plans is only 65%. This panel discussion will review the potential savings through increasing generic utilization, how plan sponsors can increase utilization of generics, and the impact of implementing changes.

Jim Keon, President of CGPA, will discuss the industry's COVID-19 response, the pricing of generic pharmaceutical products in Canada, and the potential savings to plan sponsors of increasing their use of generic prescription medicines.

Joanne Jung, Pharmacy Practice Leader at Willis Towers Watson, will elaborate on real-life experience in implementing mandatory generic substitution for their clients.

Mark Rolnick of Green Shield Canada will provide a carrier perspective on the impact of implementing mandatory generic substitution on a block of business, including communications, cost benefits.

You can register to view this webinar on demand

Fees and Registration

Membership Types	Regular Price	Plan Sponsor Price
Member	$0.00 CDN	$0.00 CDN
Plan Sponsor Individual Member	$0.00 CDN	$0.00 CDN
Associate Member	$0.00 CDN	$0.00 CDN
Student Membership	$0.00 CDN	-
Non Member	$65.00 CDN	$50.00 CDN

Cancellation Policy

SPEAKERS
	Joanne Jung, B.Sc. (Pharm.) Pharmacy Practice Leader Willis Towers Watson As a practicing pharmacist and experienced health and benefits practitioner, Joanne brings a unique combination of expertise and hands-on experience. Joanne has partnered with a broad spectrum of employer, trustee and union groups to optimize drug plan utilization and mitigate costs. She has also advised a wide range of organizations in both the private and public sectors across Canada to design and implement health and benefit management strategies. Prior to joining Willis Towers Watson, Joanne worked at British Columbia’s largest health authority for over 20 years, gaining critical acclaim for her innovation in developing the clinical practice of hospital pharmacists. Joanne completed her pharmacy degree at the University of British Columbia followed by a hospital residency at St. Paul’s Hospital. As an industry professional, Joanne has published several research papers and is a frequent speaker at industry events. She is a past member of several Canadian Life and Health Insurance Association committees and has served on a number of national advisory boards.

	Jim Keon President Canadian Generic Pharmaceutical Association (CGPA) Jim Keon is President of the Canadian Generic Pharmaceutical Association (CGPA), and President of Biosimilars Canada organizations representing Canada’s generic and biosimilar pharmaceutical sectors. Jim graduated with an M.A. in Economics from Queen’s University and has more than 25 years experience in the pharmaceutical sector. Jim has served as President of the CGPA since 1998 and was named the founding President of Biosimilars Canada in January 2015. Prior to joining CGPA in 1994 he held senior positions in the federal government and was directly involved in international trade negotiations for NAFTA and the WTO, as well as Canada’s inter-provincial trade negotiations. Jim is a past Chair and a current member of the Management Committee of the International Generic and Biosimilars Medicines Association (IGBA). The IGBA is committed to promoting the interests of generic and biosimilars medicines around the world.

	Mark Rolnick Executive Vice President, Pharmacy Innovation & Patient Experience Green Shield Canada Mark Rolnick is the Executive Vice President, Pharmacy Innovation & Patient Experience at Green Shield Canada (GSC). He is highly skilled at identifying emerging clinical and business challenges and turning them into opportunities to develop unique pharmacy and patient care solutions that promote the health and well-being of plan members and Canadians overall. As a result, Mark’s strategic and operational leadership ensures GSC customers benefit from relevant and proactive pharmacy, formulary, and drug claims strategies that strengthen long-term satisfaction. As a seasoned innovator, his diverse background spans clinical services, pharmaceutical industry, and insurance roles.

Mark Rolnick is the Executive Vice President, Pharmacy Innovation & Patient Experience at Green Shield Canada (GSC). He is highly skilled at identifying emerging clinical and business challenges and turning them into opportunities to develop unique pharmacy and patient care solutions that promote the health and well-being of plan members and Canadians overall. As a result, Mark’s strategic and operational leadership ensures GSC customers benefit from relevant and proactive pharmacy, formulary, and drug claims strategies that strengthen long-term satisfaction. As a seasoned innovator, his diverse background spans clinical services, pharmaceutical industry, and insurance roles.

National Webinar - Bridging the Gap

Increasing private sector drug benefit plan sustainability

Upcoming Events